Parkinson’s research map highlights growing attention to gut microbes
An analysis of publications identified active themes and contributors in work on microglia and Parkinson’s disease; it did not test a treatment.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This paper maps where research attention is concentrated in studies of microglia and Parkinson’s disease. Gut microbes and the NLRP3 inflammasome emerged as growing topics, alongside established themes involving inflammation and neurodegeneration. These findings describe publishing activity and research priorities; they do not demonstrate that targeting any of these pathways improves patient outcomes.
The abstract does not report the number of publications, search dates or detailed selection criteria. Bibliometric prominence cannot establish evidence quality or treatment effectiveness.
How research was mapped
Researchers used publication records and software to visualize patterns in the literature. Their results identified leading countries, institutions, journals and authors, along with keywords appearing frequently in research on microglia and Parkinson’s disease.
What attracted attention
China and the United States led publication contributions. Common topics included inflammation, alpha-synuclein, microglial activation and oxidative stress. The authors highlighted gut microbiota and the NLRP3 inflammasome as areas drawing increasing interest.
The original publication
Microglia-associated research in Parkinson's disease: a bibliometric analysis.
Chen YJ, Xie MR, Zhou SQ et al.
Front Aging Neurosci · 2025
- PubMed ID
- 41035823
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.